SCHEMBL231284

SCHEMBL231284

C1CCC(C2CCC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1943583 1.00 ALDH1A1 (0.89)
SCHEMBL31602113 1.00
SCHEMBL30756 1.00
SCHEMBL28617884 1.00
SCHEMBL7178533 1.00
SCHEMBL435762 0.95 ALDH1A1 (0.80)
SCHEMBL335119 0.95 ALDH1A1 (0.80)
SCHEMBL10596318 0.95 ALDH1A1 (0.80)
SCHEMBL31443055 0.95 ALDH1A1 (0.80)
SCHEMBL10783863 0.95 ALDH1A1 (0.80)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 749 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023244059-A1 METHODS OF TREATING CANCER USING DUAL ANDROGEN RECEPTOR AND PDE5 INHIBITOR COMPOUNDS ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-12-21 WO claimed
WO-2023208165-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 四川海思科制药有限公司 2023-11-02 WO claimed
WO-2023202687-A1 PYRAZINONE DERIVATIVE AND USE THEREOF IN MEDICINE 四川海思科制药有限公司 2023-10-26 WO claimed
EP-4259634-A1 NOVEL COMPOUNDS AS ANDROGEN RECEPTOR AND PHOSPHODIESTERASE DUAL INHIBITOR Ildong Pharmaceutical Co., Ltd. (KR) 2023-10-18 EP claimed
CN-116848116-A Novel compounds as dual androgen receptor and phosphodiesterase inhibitors 日东制药株式会社 2023-10-03 CN claimed
WO-2023151697-A1 METTL3 INHIBITOR AND COMPOSITION, AND APPLICATION OF SAME IN MEDICINE 四川海思科制药有限公司 2023-08-17 WO claimed
US-20230242532-A1 TETRACYCLIC PYRIMIDINONE COMPOUND, PREPARATION METHOD THEREFOR, AND COMPOSITION AND USE THEREOF NEUSCO BIOTECH LIMITED (CN) 2023-08-03 US claimed
WO-2023143384-A1 COMPOUND FOR INHIBITING OR DEGRADING HPK1 KINASE AND MEDICAL USE THEREOF 四川海思科制药有限公司 2023-08-03 WO claimed
WO-2023143370-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND AS WELL AS COMPOSITION AND PHARMACEUTICAL USE THEREOF 四川海思科制药有限公司 2023-08-03 WO claimed
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO claimed
WO-1998022434-A1 GLYOXYLIC ACID AMIDES BAYER AKTIENGESELLSCHAFT (DE) 1998-05-28 WO claimed
EP-0809637-A1 FUNGICIDAL AZA-HETEROCYCLOALKENES BAYER AG (DE) 1997-12-03 EP claimed
WO-1997019053-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-05-29 WO claimed
WO-1996025406-A1 FUNGICIDAL AZA-HETEROCYCLOALKENES BAYER AKTIENGESELLSCHAFT (DE) 1996-08-22 WO claimed
EP-0618898-A1 AMIDINO DERIVATIVES AND THEIR USE AS NITRIC OXIDE SYNTHASE INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1994-10-12 EP claimed
EP-0332991-B1 Substituted triazoles BAYER AG (DE) 1993-11-10 EP claimed
WO-1993013055-A1 AMIDINO DERIVATIVES AND THEIR USE AS NITRIC OXIDE SYNTHASE INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1993-07-08 WO claimed
EP-0371664-A2 Catalyst supports BASF Aktiengesellschaft (DE) 1990-06-06 EP claimed
EP-0332991-A1 Substituted triazoles BAYER AG (DE) 1989-09-20 EP claimed
EP-0251126-A2 1,7-substituted heptyne-2-ones MARION MERRELL DOW INC. (US) 1988-01-07 EP claimed